(Q37157069)

18 August 2017

1 reference

title

Caring for the treatment-experienced breast cancer patient: the pharmacist's role (English)

1 reference

18 August 2017

1 reference

1 reference

Sally Yowell Barbour

1

1 reference

18 August 2017

publication date

1 May 2008

1 reference

American Journal of Health-System Pharmacy

18 August 2017

published in

1 reference

18 August 2017

volume

65

1 reference

18 August 2017

issue

10 Suppl 3

1 reference

18 August 2017

page(s)

S16-22

1 reference

Risk models for predicting chemotherapy-induced neutropenia

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

Dose intensity of standard adjuvant CMF with granulocyte colony-stimulating factor for premenopausal patients with node-positive breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

A predictive model for neutropenia associated with cancer chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

Chemotherapy-induced anemia in adults: incidence and treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

On the receiving end--patient perception of the side-effects of cancer chemotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

Proposal for classifying the acute emetogenicity of cancer chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

Control of chemotherapy-induced emesis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--an update.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

Peripheral neuropathy induced by microtubule-stabilizing agents.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere).

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

Chemotherapy-induced peripheral neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

Patient compliance: recognition of factors involved and suggestions for promoting compliance with therapeutic regimens

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP080090

31 March 2020

Identifiers

DOI

10.2146/AJHP080090

1 reference

18 August 2017

1 reference